Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Case Comprehensive Cancer Center
Assiut University
RenJi Hospital
Women's Hospital School Of Medicine Zhejiang University
Obstetrics & Gynecology Hospital of Fudan University
Azienda Policlinico Umberto I
Hubei Cancer Hospital
Mercy Medical Center
Assiut University
Clinica Universidad de Navarra, Universidad de Navarra
Sichuan Cancer Hospital and Research Institute
Professor Fernando Figueira Integral Medicine Institute
University of Kentucky
Catholic University of the Sacred Heart
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Mayo Clinic
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Japan Clinical Oncology Group
Japan Clinical Oncology Group
Capital Medical University
University Hospital, Bonn